Target intelligence / Profile preview

Alpha-1 antitrypsin (AAT)

Target
AAT
Molecular classification
Serine protease inhibitor, Serpin
01

Overview

Alpha-1 antitrypsin (AAT) is a serine protease inhibitor primarily produced in the liver. Its main function is to protect tissues, especially in the lungs, from damage by proteolytic enzymes such as neutrophil elastase. Deficiency in AAT leads to unopposed activity of neutrophil elastase, resulting in tissue damage and diseases such as emphysema and liver cirrhosis.

Other names
alpha-1 proteinase inhibitoralpha-1 protease inhibitorSerpin family member
02

Mechanism of action

Inhibits neutrophil elastase and other serine proteases by forming a stable complex, preventing tissue degradation.

03

Biological functions

Proteolytic enzyme inhibitionInflammation controlTissue protection
04

Disease associations

COPDEmphysemaLiver cirrhosisHepatocellular carcinomaPanniculitis
05

Safety considerations

Risk of emphysema/COPD in deficiencyRisk of liver disease in deficiencyImpact of smoking on AAT activityPotential for misfolding and aggregation in deficiency
06

Biomarkers

AAT serum levelsSERPINA1 genotype

Beyond the preview

Go deeper on Alpha-1 antitrypsin (AAT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-1 antitrypsin (AAT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call